The data that led an AI biotech to pick up Novo's Parkinson's stem cell therapy

Cellular Intelligence's STEM-PD data, presented at ISSCR and in Nature Medicine, shows safety signals and reduced medication use in Parkinson's patients ahead of a planned Phase 2.

Raccontata daendpoints.news